In the BioHarmony Drug Report Database

"Preview" Icon

Salmeterol xinafoate

Serevent (salmeterol xinafoate) is a small molecule pharmaceutical. Salmeterol xinafoate was first approved as Serevent on 1994-02-04. It is used to treat asthma and bronchial spasm in the USA. It is known to target beta-2 adrenergic receptor.

 

Trade Name

 

Serevent
 

Common Name

 

salmeterol xinafoate
 

ChEMBL ID

 

CHEMBL1082607
 

Indication

 

asthma, bronchial spasm
 

Drug Class

 

Bronchodilators (phenethylamine derivatives); anti-inflammatory agents (salicylic acid derivatives)

Image (chem structure or protein)

Salmeterol xinafoate structure rendering